Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraneoplastic peripheral neuropathy

P S Smitt1, J B Posner

  • 1Dr Daniel den Hoed Kliniek, Department of Neuro-Oncology, Rotterdam, The Netherlands.

Bailliere'S Clinical Neurology
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration.

Journal of neurology, neurosurgery, and psychiatry·2006
Same author

Les syndromes paranéoplasiques.

Revue neurologique·2002
Same author

Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.

Cancer research·2001
Same author

The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2001
Same author

Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.

Annals of neurology·2001
Same author

Yet another paraneoplastic antibody.

Annals of neurology·2001
Same journal

Remyelination in demyelinating disease.

Bailliere's clinical neurology·1999
Same journal

Other immunomodulatory therapies in multiple sclerosis.

Bailliere's clinical neurology·1999
Same journal

Copolymer-1.

Bailliere's clinical neurology·1999
Same journal

Interferon beta 1a.

Bailliere's clinical neurology·1999
Same journal

Treatment of multiple sclerosis with interferon beta 1b.

Bailliere's clinical neurology·1999
Same journal

The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis.

Bailliere's clinical neurology·1999
See all related articles

Paraneoplastic peripheral neuropathies may be an early indicator of hidden cancer. Identifying associated autoantibodies can aid in early diagnosis and treatment of the underlying malignancy.

Area of Science:

  • Neurology
  • Oncology
  • Immunology

Background:

  • Paraneoplastic peripheral neuropathies are rare neurological disorders.
  • They are distinct from neuropathies caused directly by cancer or its treatments.
  • These conditions can be the initial manifestation of an undetected cancer.

Purpose of the Study:

  • To highlight the significance of paraneoplastic neuropathies in cancer diagnosis.
  • To discuss the role of autoantibodies in paraneoplastic disorders.
  • To explore the diagnostic and therapeutic implications of autoantibody discovery.

Main Methods:

  • Review of existing literature on paraneoplastic neuropathies.
  • Analysis of the association between autoantibodies and neurological symptoms.

Related Experiment Videos

  • Correlation of autoantibody presence with underlying cancer types.

    • Main Results:

    • Paraneoplastic neuropathies, though uncommon, are crucial diagnostic markers.
    • Autoantibodies targeting neural and cancer proteins are characteristic of these disorders.
    • Detection of specific autoantibodies can facilitate early cancer identification.

    Conclusions:

    • Paraneoplastic neuropathies warrant thorough investigation for underlying malignancies.
    • Autoantibody profiling offers a promising avenue for early cancer detection.
    • Timely diagnosis through autoantibody discovery may improve patient outcomes and enable potential cures.